Pfizer buys Wyeth

4 votes
Recommend

The world's largest drug maker will pay $68 billion for Wyeth, boosting its pipeline as it gets closer to losing its patent on the cholesterol drug Lipitor. Pfizer is paying $68 billion dollars for rival drug maker Wyeth, while announcing lower quarterly earnings and plans to slash its dividend in half. Pfizer's acquisition successfully tapped into the credit markets-- a sign of confidence in the company's strategy, according to analysts. Bobbi Rebell reports.

Tags: Wyeth, Pfizer

China eyes fewer car, steel players

China wants to consolidate its steel and car industries, calling on key firms to take dominant...
» view video

Business Update: Asian stocks surge

Asian shares jump on U.S. plan to clear $1 trillion of banks' toxic assets. * Asian markets...
» view video

Business Update: Jobless record

The number of Americans receiving unemployment benefits hit another record, but there are signs new...
» view video

The Fed's big fix

The Federal Reserve is using every weapon in its arsenal to battle the recession. The markets...
» view video

Generic drug industry outlook

Director of Generics at Thomson Scientific Kate Kuhrt provides insight on the landscape of generic...
» view video

» browse all category videos

Video categories

» Home	» Specials	» World
» Business	» Technology	» U.S.
» Science	» Health	» Movie Reviews
» Movies	» Music	» People
» Sports	» Gadgets	» Video Games

SHARE THE VIDEO:

		Del.icio.us			Digg			Stumble Upon
		Facebook			Newsvine			Mixx

» E-mail To A Friend

Photos Gallery